Yuva Biosciences focuses on enhancing mitochondrial health as a means to combat the effects of aging, particularly in relation to hair loss and skin wrinkles. Their flagship product, YuvaBio® Y100™, is designed to restore mitochondrial function, which is known to decline over time and contribute to various age-related issues. By improving mitochondrial performance, these topical products aim to provide increased energy to cells, thereby supporting their overall functions and promoting a youthful appearance.

The company is actively engaged in research and development, evidenced by their recent achievements, including receiving a Therapeutic Development Fund Grant to address ovarian aging. Yuva Biosciences has also formed partnerships to expand their product offerings, such as the Elevai S-Series Hair and Scalp Care Product Line. Their innovative approach has garnered attention in the industry, with recognition for their contributions to hair loss biotechnology and a commitment to leveraging mitochondrial science for the development of effective cosmeceuticals and pharmaceuticals.

United States

Yuva Biosciences is an anti-aging company harnessing the cutting edge of mitochondrial science to develop cosmeceuticals as well as pharmaceuticals targeted at aging-related hair loss, wrinkled skin, and reduced energy. The company has secured a multimillion dollar seed round and has also entered into licensing agreements with other companies to research and develop new aesthetics products.

Yuva Biosciences

Company Details